Literature DB >> 30690890

MG53 Inhibits the Progression of Tongue Cancer Cells through Regulating PI3K-AKT Signaling Pathway: Evidence from 3D Cell Culture and Animal Model.

Wei Yin1, Yaoli Liu1, Zhuan Bian1.   

Abstract

MG53 is transcriptionally activated by the IRS-1/PI3K/AKT signal pathway, which is closely related with oncogenesis of several tumors. Here, the role of MG53 in the tumorigenesis of tongue cancer is analyzed in vitro and in vivo. The stable MG53 overexpression/knockdown SCC9 and SCC25 cells are constructed through retrovirus infection. Then a PLGA cylinder is used to provide a 3D culture environment for cell growth. Cell counting results suggest that overexpression of MG53 inhibits the cell proliferation and colony formation of SCC9 and SCC25 cells. While knockdown of MG53 has the opposite effect. Furthermore, knockdown of MG53 significantly promotes the invasion of SCC9 and SCC25 cells. Western blotting data confirm that MG53 affects the expression of the AKT signaling pathway. In a xenograft assay, knockdown of MG53 promotes the growth of xenograft which is induced by SCC25 cells in nude mice. The findings demonstrate that MG53 affects the biological behavior of human tongue cancer SCC9 and SCC25 cells.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  AKT; MG53; SCC25 cells; SCC9 cells; tongue cancer

Mesh:

Substances:

Year:  2019        PMID: 30690890     DOI: 10.1002/smll.201805492

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  4 in total

1.  Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma.

Authors:  Weiyu Dai; Jing Wang; Zhi Wang; Yizhi Xiao; Jiaying Li; Linjie Hong; Miaomiao Pei; Jieming Zhang; Ping Yang; Xiaosheng Wu; Weimei Tang; Xiaoling Jiang; Ping Jiang; Li Xiang; Aimin Li; Jianjiao Lin; Side Liu; Jide Wang
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

2.  The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling.

Authors:  Xiaomin Ma; Xiaoxiao Ma; Lihui Zhu; Yunxue Zhao; Mengmeng Chen; Tao Li; Yueke Lin; Dapeng Ma; Caiyu Sun; Lihui Han
Journal:  Oncogenesis       Date:  2022-07-20       Impact factor: 6.524

3.  TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA.

Authors:  Zheng Wang; Haixia Li; Hongxia Wang; Xin Li; Qiong Zhang; Haifang Wang; Kui Li; Yurong Qiu
Journal:  Anticancer Drugs       Date:  2022-06-01       Impact factor: 2.248

4.  MG53 inhibits angiogenesis through regulating focal adhesion kinase signalling.

Authors:  Jinling Dong; Haiyan Zhou; Yongjie Li; Rong Li; Ni Chen; Youkun Zheng; Xin Deng; Mao Luo; Jianbo Wu; Liqun Wang
Journal:  J Cell Mol Med       Date:  2021-07-09       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.